The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 0004) is a clinical research site located in Columbus, Ohio, United States 43210.
Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.
The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 0004) has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma.
Sponsors: Merck Sharp & Dohme LLC.
Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 0004) has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 0004) has 1 clinical trials on record, with 1 currently active. Their work covers Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma.
The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 0004) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.